A Stimulated Society
Coffee, tea, mate, cocoa, guarana, coca leaf, ephedra… a large part of humanity turns to some form of stimulant every day. The drive to feel active and sustain daily efforts with an extra boost of energy is nearly universal and transcends all cultures.
When we hear the word “stimulant,” the mind immediately jumps to amphetamines or cocaine. But coffee is also a stimulant: the sense of alertness it produces follows the same basic logic—the modulation of activity in specific brain circuits and excitatory neurotransmitters. The fact that one substance is found in a supermarket while another is prohibited does not reflect a clear pharmacological boundary, but rather a legal, cultural, and political history. It is worth keeping this in mind, without implying that all substances are equivalent: potency, safety margins, and dependence potential vary enormously from one to another.
Among the milder substances circulating in the universe of so-called “nootropics” or “cognitive enhancers,” one that is relatively unknown outside of specialized circles appears with some frequency: sulbutiamine.
What Is Sulbutiamine?
Sulbutiamine is a compound derived from thiamine, or vitamin B1. Its distinguishing feature is that it is lipophilic, meaning it is fat-soluble, unlike natural thiamine, which is water-soluble. This property allows it to better traverse the body’s barriers—including the blood-brain barrier—and reach the brain more easily than the parent vitamin.
In countries where it has been marketed as a medication, product inserts have associated it with the treatment of asthenia (a persistent feeling of fatigue or lack of energy) and certain states of apathy. Subjectively, its proponents describe an effect comparable to a strong coffee but more prolonged and, in theory, with less nervousness, in addition to a possible action on memory and concentration. It is worth emphasizing the “in theory”: clinical evidence on this is limited and highly inconsistent, as we shall see.
From a Deficiency Disease to a Laboratory Derivative
The history of sulbutiamine begins with a very real public health problem. Until well into the 20th century, in areas of Asia where white rice was the almost exclusive staple of the diet, beriberi was a frequent disease. Removing the husk from the rice eliminated the part rich in vitamin B1, and prolonged deficiency caused neurological and cardiac disorders.
Japanese naval physician Takaki Kanehiro linked diet to the disease through observations of sailors during the 1880s. Years later, Dutch physiologist Christiaan Eijkman confirmed the dietary origin of beriberi; his work, along with that of Frederick Gowland Hopkins on vitamins, was recognized with the Nobel Prize in Medicine in 1929.
Interest in thiamine subsequently led to the search for more effective versions. The idea was simple: if its affinity for fats were increased, the body would absorb and utilize it better, as water-soluble thiamine is excreted rapidly and barely accumulates. The first fat-soluble derivative, allithiamine, was identified in 1951. From there, other compounds with better pharmacokinetic properties were synthesized, among them sulbutiamine, whose first known references date back to the early 1970s. In essence, its great advantage over thiamine is this increased bioavailability.
The “Brain Doping” Narrative: Where the Enthusiasm Comes From
Sulbutiamine carries a reputation that far exceeds what science firmly supports. Much of this fame stems from the popular literature of the 1980s and 1990s regarding “medications for self-improvement” and “smart drugs,” a genre that often mixed factual data with optimistic claims and personal testimonials presented almost as proof.
That type of narrative—the enthusiast who discovers the miracle substance their doctor never prescribed—is attractive, but it is also exactly the pattern that should raise red flags. An author’s subjective experience is not equivalent to evidence, and self-experimentation celebrated without verification is one of the areas where it is easiest to confuse a real effect with a placebo or the simple relief of a previous deficiency.
Critical Reading
Beyond the enthusiasm, it is worth organizing what we know and what we do not:
- Evidence is limited. The available studies on sulbutiamine are scarce, often outdated, with small sample sizes and inconclusive results. Just because a product insert lists certain indications does not mean the effect is solidly demonstrated in a healthy population seeking to “perform better.”
- It is not an innocuous vitamin just because it is “derived from a vitamin.” The chemical modification that makes it fat-soluble changes its behavior in the body. Cases of tolerance and problematic use with escalating amounts have been described in people who took it regularly.
- Perceived effects can be deceptive. In someone with a real B1 deficit, correcting the deficiency produces improvement; in someone without a deficit, much of the sensation of energy may be due to expectation. Distinguishing between the two requires more than just one’s own impression.
- Variable legal and marketing status. Its availability and regulation differ greatly by country and have changed over time. Being “available in pharmacies” in one place does not guarantee efficacy or appropriateness in another context.
Harm Reduction
Educational content written from a harm reduction perspective and with respect for individual freedom. It is not a substitute for advice from a healthcare professional and is not intended to encourage or condemn any drug use. If someone is considering a substance of this type, it is prudent to start with a few basic ideas:
- Persistent fatigue, apathy, or concentration problems may have underlying causes that should be investigated (sleep, iron levels, thyroid, mood, habits). Seeking a “stimulant” before understanding the cause may mask a problem rather than solve it.
- Any product that acts on the nervous system can interact with medication or pre-existing health conditions; consulting a healthcare professional is the appropriate path.
- Be wary of stories claiming “no side effects” and “only benefits”: no active substance fulfills that promise.
In a future installment, we will expand on how sulbutiamine fits into the confusing landscape of nootropics and what the most recent research actually says.
